NCT03015103

Brief Summary

The purpose of this study is to prove the product tested does not cause photoirritation or photosensitization reactions when exposed to sun light.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2016

Completed
3 days until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 9, 2017

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2017

Completed
Last Updated

January 9, 2017

Status Verified

December 1, 2016

Enrollment Period

1 month

First QC Date

December 29, 2016

Last Update Submit

January 5, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Photoirritation as measured through the use of dressings containing tested product and placebo

    The photoirritation will be measured with the use of four dressings that will be applied in the volunteer (3 dresssings containing different placebos and 1 containing the product). After some hours, the region is evaluated and radiated with UVA. That procedure occurs during the period of five days.

    5 days

  • Photosensitization as measured through the use of dressings containing tested product and placebo

    The photosensitization will be measured with the use of four dressings that will be applied in the volunteer (3 dresssings containing different placebos and 1 containing the product). After some hours, the region is evaluated and radiated with UVA. That procedure occurs during the period of 32 days.

    32 days

Study Arms (1)

Experimental group

EXPERIMENTAL

This study is designed as a single group assignment, because the 4 dressings (3 placebos and 1 containing the product) will be applied in all volunteers. This means that the region in which the tested product will be applied will be compared with the other placebo regions in the same volunteer.

Device: Intimate Lubrificant Gel

Interventions

All the volunteers will receive the application of four dressings (3 placebos and 1 containing the tested product). After a certain period of time, photoirritation and photosensitization will be measured through the evaluation of tested region.

Experimental group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 to 70 years old;
  • Skin types: I (light caucasian) or III (light brown);
  • Intact skin where the product will be applied;
  • Agreement to comply with the test procedures and attend the clinic in the days and fixed times for medical assessments and application and reading of dressings
  • Signature of informed consent form

You may not qualify if:

  • Pregnancy and lactation
  • Use of anti-inflammatory and immunosuppressive from 30 days up to three months prior to selection;
  • Diseases that cause immune suppression;
  • Use of photosensitizing drugs;
  • History or photodermatoses activities;
  • Personal or family history of photoinduced skin cancer;
  • Presence of precursor lesions of skin cancer, such as melanocytic nevi and actinic keratoses;
  • Intense sun exposure in the experiment area Use of new drugs and/or cosmetics during the experiment;
  • Previous participation in a study with the same product under test;
  • Relevant medical history or current evidence of alcohol or other drugs abuse;
  • Known historical or suspected intolerance to any ingredient of the product under study (product under test or comparator);
  • Sponsor's employees involved in the study, or close family member of an employee involved in the study;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
SINGLE
Who Masked
PARTICIPANT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2016

First Posted

January 9, 2017

Study Start

January 1, 2017

Primary Completion

February 1, 2017

Last Updated

January 9, 2017

Record last verified: 2016-12